Jiangsu Jibeier Pharmaceutical Co Ltd Sustainability Reports
The company engages in the research, development, manufacture, and sales of pharmaceutical products. Its main product offerings include leucocyte-increasing drugs and compound anti-hypertensive formulations.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG001VCP4W5
2 reports from 2023 to 2025
